Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular predictors for the course of disease and individualized therapy in pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen - 1 Aug 2020

Damanakis A I, Gebauer F, Bruns C J

Abstract excerpt

The understanding of the development of pancreatic cancer has undergone considerable development over the last two decades. This is mainly due to the progress and use of methods for molecular biological analysis of pancreatic carcinomas. There is now a fundamental understanding with respect to the genetic drivers for the development of pancreatic cancer and the correlation with clinical data as well as the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Pancreatic Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Mutation

Share to Pancreatic Neoplasms

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 32405728
DOI: 10.1007/s00104-020-01172-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular predictors for the course of disease and individualized therapy in pancreatic cancer].PMID 32405728Read ↗

Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer.Semantic proximity Read ↗

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.Semantic proximity Read ↗

Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.Semantic proximity Read ↗

[Genetic aspects of pancreatic cancer].Semantic proximity Read ↗

[Pancreatic carcinogenesis. Clinical implications].Semantic proximity Read ↗

Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.Semantic proximity Read ↗

The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.Semantic proximity Read ↗

[Molecular factors of pancreatic cancer pathogenesis and prognosis].Semantic proximity Read ↗

[New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].Semantic proximity Read ↗

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.Semantic proximity Read ↗

The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in Pancreatic Cancer: A Bayesian Network Meta-Analysis.Semantic proximity Read ↗

Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.